FAP and neoplasm: In contrast, we observed significant time-dependent accumulation of CD45.1+GFP+ donor T cells in tumors starting as early as 1-day post-administration of FAP-CAR T cells and the tumor-infiltrating FAP-CAR T cells increased over time at least until 7 days post-administration (Fig. 2b and Supplementary Fig. 5a–c).